| UniProt ID | ZN574_HUMAN | |
|---|---|---|
| UniProt AC | Q6ZN55 | |
| Protein Name | Zinc finger protein 574 | |
| Gene Name | ZNF574 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 896 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May be involved in transcriptional regulation.. | |
| Protein Sequence | MTEESEETVLYIEHRYVCSECNQLYGSLEEVLMHQNSHVPQQHFELVGVADPGVTVATDTASGTGLYQTLVQESQYQCLECGQLLMSPSQLLEHQELHLKMMAPQEAVPAEPSPKAPPLSSSTIHYECVDCKALFASQELWLNHRQTHLRATPTKAPAPVVLGSPVVLGPPVGQARVAVEHSYRKAEEGGEGATVPSAAATTTEVVTEVELLLYKCSECSQLFQLPADFLEHQATHFPAPVPESQEPALQQEVQASSPAEVPVSQPDPLPASDHSYELRNGEAIGRDRRGRRARRNNSGEAGGAATQELFCSACDQLFLSPHQLQQHLRSHREGVFKCPLCSRVFPSPSSLDQHLGDHSSESHFLCVDCGLAFGTEALLLAHRRAHTPNPLHSCPCGKTFVNLTKFLYHRRTHGVGGVPLPTTPVPPEEPVIGFPEPAPAETGEPEAPEPPVSEETSAGPAAPGTYRCLLCSREFGKALQLTRHQRFVHRLERRHKCSICGKMFKKKSHVRNHLRTHTGERPFPCPDCSKPFNSPANLARHRLTHTGERPYRCGDCGKAFTQSSTLRQHRLVHAQHFPYRCQECGVRFHRPYRLLMHRYHHTGEYPYKCRECPRSFLLRRLLEVHQLVVHAGRQPHRCPSCGAAFPSSLRLREHRCAAAAAQAPRRFECGTCGKKVGSAARLQAHEAAHAAAGPGEVLAKEPPAPRAPRATRAPVASPAALGSTATASPAAPARRRGLECSECKKLFSTETSLQVHRRIHTGERPYPCPDCGKAFRQSTHLKDHRRLHTGERPFACEVCGKAFAISMRLAEHRRIHTGERPYSCPDCGKSYRSFSNLWKHRKTHQQQHQAAVRQQLAEAEAAVGLAVMETAVEALPLVEAIEIYPLAEAEGVQISG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTEESEETV ------CCCCHHHHE | 48.75 | 30108239 | |
| 5 | Phosphorylation | ---MTEESEETVLYI ---CCCCHHHHEEEE | 34.20 | 30108239 | |
| 113 | Phosphorylation | EAVPAEPSPKAPPLS CCCCCCCCCCCCCCC | 30.45 | 25159151 | |
| 137 | Phosphorylation | DCKALFASQELWLNH CHHHHHHCHHHHHHC | 19.49 | 17525332 | |
| 147 | Phosphorylation | LWLNHRQTHLRATPT HHHHCCCHHCCCCCC | 23.88 | 28464451 | |
| 152 | Phosphorylation | RQTHLRATPTKAPAP CCHHCCCCCCCCCCC | 25.67 | 23927012 | |
| 154 | Phosphorylation | THLRATPTKAPAPVV HHCCCCCCCCCCCEE | 35.17 | 23927012 | |
| 164 | Phosphorylation | PAPVVLGSPVVLGPP CCCEECCCCEEECCC | 15.45 | 28355574 | |
| 183 | Phosphorylation | RVAVEHSYRKAEEGG HHHHHHHHHHHHHCC | 20.31 | - | |
| 256 | Phosphorylation | LQQEVQASSPAEVPV HHHHHHHCCCCCCCC | 21.55 | 26074081 | |
| 257 | Phosphorylation | QQEVQASSPAEVPVS HHHHHHCCCCCCCCC | 31.01 | 26074081 | |
| 264 | Phosphorylation | SPAEVPVSQPDPLPA CCCCCCCCCCCCCCC | 29.90 | 26074081 | |
| 298 | Phosphorylation | RRARRNNSGEAGGAA CCCCCCCCCCCCCHH | 41.37 | 22617229 | |
| 306 | Phosphorylation | GEAGGAATQELFCSA CCCCCHHHHHHHHHH | 23.26 | 22617229 | |
| 312 | Phosphorylation | ATQELFCSACDQLFL HHHHHHHHHHHHHCC | 25.29 | 28464451 | |
| 320 | Phosphorylation | ACDQLFLSPHQLQQH HHHHHCCCHHHHHHH | 17.01 | 20068231 | |
| 387 (in isoform 2) | Phosphorylation | - | 24.63 | 21406692 | |
| 387 | Phosphorylation | LAHRRAHTPNPLHSC HHHHHCCCCCCCCCC | 24.63 | 28985074 | |
| 405 (in isoform 1) | Ubiquitination | - | 36.22 | 21890473 | |
| 405 | Ubiquitination | KTFVNLTKFLYHRRT HHHHHHHHHHHCCCC | 36.22 | 2189047 | |
| 409 (in isoform 2) | Phosphorylation | - | 18.20 | 21406692 | |
| 422 | Phosphorylation | VGGVPLPTTPVPPEE CCCCCCCCCCCCCCC | 51.95 | 28348404 | |
| 423 | Phosphorylation | GGVPLPTTPVPPEEP CCCCCCCCCCCCCCC | 21.98 | 28348404 | |
| 477 | Sumoylation | LCSREFGKALQLTRH EEEHHHHHHHHHHHH | 51.77 | - | |
| 477 | Ubiquitination | LCSREFGKALQLTRH EEEHHHHHHHHHHHH | 51.77 | - | |
| 477 | Sumoylation | LCSREFGKALQLTRH EEEHHHHHHHHHHHH | 51.77 | - | |
| 494 (in isoform 2) | Ubiquitination | - | 25.00 | 21890473 | |
| 495 (in isoform 2) | Ubiquitination | - | 41.52 | 21890473 | |
| 502 | Acetylation | HKCSICGKMFKKKSH HCCCCCHHHHCCHHH | 36.43 | 30593797 | |
| 506 | Acetylation | ICGKMFKKKSHVRNH CCHHHHCCHHHHHHH | 48.52 | 30593803 | |
| 507 | Acetylation | CGKMFKKKSHVRNHL CHHHHCCHHHHHHHH | 46.51 | 30593809 | |
| 508 | Phosphorylation | GKMFKKKSHVRNHLR HHHHCCHHHHHHHHH | 35.77 | - | |
| 518 | Phosphorylation | RNHLRTHTGERPFPC HHHHHHCCCCCCCCC | 39.87 | 25159151 | |
| 530 | Ubiquitination | FPCPDCSKPFNSPAN CCCCCCCCCCCCHHH | 61.02 | - | |
| 534 | Phosphorylation | DCSKPFNSPANLARH CCCCCCCCHHHHHHH | 26.26 | 22199227 | |
| 544 | Phosphorylation | NLARHRLTHTGERPY HHHHHCCCCCCCCCE | 19.83 | 28348404 | |
| 546 | Phosphorylation | ARHRLTHTGERPYRC HHHCCCCCCCCCEEC | 35.19 | 29214152 | |
| 558 | Ubiquitination | YRCGDCGKAFTQSST EECCCCCCCCCCCHH | 46.81 | - | |
| 566 (in isoform 2) | Ubiquitination | - | 5.54 | - | |
| 602 | Phosphorylation | LMHRYHHTGEYPYKC HEECCCCCCCCCCCC | 20.56 | 29214152 | |
| 605 | Phosphorylation | RYHHTGEYPYKCREC CCCCCCCCCCCCCCC | 17.13 | 17360941 | |
| 608 | Ubiquitination | HTGEYPYKCRECPRS CCCCCCCCCCCCCHH | 23.47 | - | |
| 615 | Phosphorylation | KCRECPRSFLLRRLL CCCCCCHHHHHHHHH | 12.85 | 24719451 | |
| 619 (in isoform 2) | Ubiquitination | - | 29.37 | - | |
| 647 (in isoform 2) | Ubiquitination | - | 35.23 | - | |
| 648 | Phosphorylation | CGAAFPSSLRLREHR CCCCCCCCHHHHHHH | 20.11 | 17081983 | |
| 674 | Acetylation | FECGTCGKKVGSAAR EECCCCCCCCCHHHH | 46.57 | 30593791 | |
| 697 (in isoform 2) | Ubiquitination | - | 8.58 | - | |
| 700 | Ubiquitination | GPGEVLAKEPPAPRA CCCCHHCCCCCCCCC | 67.60 | - | |
| 711 | Phosphorylation | APRAPRATRAPVASP CCCCCCCCCCCCCCH | 28.74 | 23090842 | |
| 717 | Phosphorylation | ATRAPVASPAALGST CCCCCCCCHHHHCCC | 18.46 | 25159151 | |
| 723 | Phosphorylation | ASPAALGSTATASPA CCHHHHCCCCCCCCC | 18.73 | 25159151 | |
| 724 | Phosphorylation | SPAALGSTATASPAA CHHHHCCCCCCCCCC | 26.65 | 16964243 | |
| 726 | Phosphorylation | AALGSTATASPAAPA HHHCCCCCCCCCCHH | 27.96 | 22199227 | |
| 728 | Phosphorylation | LGSTATASPAAPARR HCCCCCCCCCCHHHH | 15.66 | 25159151 | |
| 748 | Phosphorylation | SECKKLFSTETSLQV HHHHHHHCCCCCHHH | 35.45 | 24247654 | |
| 761 | Phosphorylation | QVHRRIHTGERPYPC HHHHHCCCCCCCCCC | 38.06 | 28985074 | |
| 779 | Phosphorylation | GKAFRQSTHLKDHRR HHHHHHCCCCCCCCC | 23.92 | 27251275 | |
| 789 (in isoform 2) | Ubiquitination | - | 45.38 | - | |
| 789 | Phosphorylation | KDHRRLHTGERPFAC CCCCCCCCCCCCCHH | 45.38 | 25159151 | |
| 806 | Phosphorylation | CGKAFAISMRLAEHR CCHHHHHHHHHHHHC | 8.40 | 24719451 | |
| 817 | Phosphorylation | AEHRRIHTGERPYSC HHHCCCCCCCCCCCC | 38.06 | 28674419 | |
| 832 | Asymmetric dimethylarginine | PDCGKSYRSFSNLWK CCCCCCHHHHHHHHH | 38.01 | - | |
| 832 | Methylation | PDCGKSYRSFSNLWK CCCCCCHHHHHHHHH | 38.01 | 24129315 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN574_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN574_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN574_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| SHCBP_HUMAN | SHCBP1 | physical | 28514442 | |
| P52K_HUMAN | PRKRIR | physical | 28514442 | |
| TRI41_HUMAN | TRIM41 | physical | 28514442 | |
| ANR28_HUMAN | ANKRD28 | physical | 28514442 | |
| IFFO1_HUMAN | IFFO1 | physical | 28514442 | |
| PP6R2_HUMAN | PPP6R2 | physical | 28514442 | |
| KBTB7_HUMAN | KBTBD7 | physical | 28514442 | |
| LTBP4_HUMAN | LTBP4 | physical | 28514442 | |
| KBTB6_HUMAN | KBTBD6 | physical | 28514442 | |
| SART3_HUMAN | SART3 | physical | 28514442 | |
| UBE2O_HUMAN | UBE2O | physical | 28514442 | |
| RT09_HUMAN | MRPS9 | physical | 28514442 | |
| CENPB_HUMAN | CENPB | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; THR-154; SER-164;SER-298; SER-717 AND SER-728, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-728, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-137, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164; THR-724 ANDSER-728, AND MASS SPECTROMETRY. | |